Prostate Cancer
Influencing Best Practices for Genomic and Germline Testing in Urology.
September 1, 2023
Impact of androgen receptor alterations on cell-free DNA genomic profiling on survival outcomes in metastatic castration-resistant prostate cancer.
September 1, 2023
Trends in prostate cancer screening in the pre- and peri-COVID-19 Pandemic period.
September 1, 2023
Elevated periprostatic venous testosterone correlates with prostate cancer progression after radical prostatectomy.
September 1, 2023
A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus.
September 1, 2023
In-office dispensing of oral targeted agents by urology practices in men with advanced prostate cancer.
August 31, 2023
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.
August 30, 2023
Preclinical Evaluation of a New Series of Albumin-Binding 177Lu-Labeled PSMA-Based Low-Molecular-Weight Radiotherapeutics.
August 30, 2023